U.S. Congress and Obama Administration urged to examine dark side of Uribe years

first_img RSF begins research into mechanisms for protecting journalists in Latin America By giving a platform to Duque and Morris, we are obviously intending to maintain all the vigilance necessary to ensure that justice is rendered in one of the biggest domestic spying scandals of recent years, one that involved multiple violations or the right to impart and receive news and information. And by giving them a platform in Washington, we are seeking the attention of a country that is linked to Colombia by a “Plan” of the same name, and by an accord granting the US army seven military bases on Colombian territory.The degree to which technology and information exchanges between intelligence services facilitated the DAS dirty tricks during this period also remains to be established. And do they still? Barack Obama’s promises as a candidate to adapt his foreign policy to human rights imperatives could find room for implementation here.Some members of the U.S. Congress raised human rights issues when Plan Colombia was debated. This kind of cooperation should not be undertaken or renewed without taking account of fundamental freedoms. The United States needs to examine the dark side of the Uribe years.Reporters Without Borders has meanwhile learned that Rodolfo Maya Aricape, an indigenous leader and journalist with Radio Payumat, a community radio station, was murdered on 14 October. When we visited Colombia together with the World Association of Community Radio Broadcasters (AMARC), we met with the North Cauca Association of Indigenous Councils (ACIN), to which Radio Payumat is affiliated.Its representatives told us how the local communities, and their journalists, are constantly caught in a trap between, on the one hand, the army and paramilitaries, who accuse them of being “in the pay of the guerrillas” and, on the other, the Revolutionary Armed Forces of Colombia (FARC), which accuses them of “collaborating with the state.”Maya was shot dead at his home in front of his family by two unidentified gunmen. According to ACIN and the Press Freedom Foundation (FLIP), the Reporters Without Borders partner organization in Colombia, graffiti had branded Maya as a “FARC member” shortly before his death. Colombia’s civil war is far from over. 2011-2020: A study of journalist murders in Latin America confirms the importance of strengthening protection policies Organisation October 21, 2020 Find out more ColombiaAmericas to go further ColombiaAmericas Radio Nizkor journalist Claudia Julieta Duque is planning to bring a legal action against former President Alvaro Uribe in connection with the illegal phone-tapping, smear campaigns and acts of sabotage carried out against her by the Administrative Department of Security (DAS), Colombia’s leading intelligence agency.Duque will explain her plans at a news conference that Reporters Without Borders is hosting at the National Press Club in Washington D.C. at 7 p.m. today. Hollman Morris, producer of the current affairs programme Contravía on Colombia’s state-owned Canal Uno TV, who is another victim of DAS dirty tricks, will also take part. Details of the news conference and participants are available here. The so-called “DASgate” scandal, the subject of a Reporters Without Borders special visit and report last May, is now reaching the highest level of the Colombian state. Former President Uribe, who handed over to his elected successor in August after completing two four-year terms, is due to be questioned about it by a special congressional commission but he is not facing any criminal charges.To what degree did Uribe participate in the incredible misuse of the intelligence services to target the opponents of his “democratic security” policies? It should be up to the courts to decide.President Uribe’s heavily publicised personal attacks on his critics clearly had a major impact. Branded by the president in person on television, as shown in this video recording made during our visit, Canal Uno programme director Daniel Coronell was the target of serious threats and had to spend time in self-imposed exile, as did his two colleagues at today’s news conference. News May 13, 2021 Find out more Follow the news on Colombia RSF_en October 28, 2010 – Updated on January 20, 2016 U.S. Congress and Obama Administration urged to examine dark side of Uribe years Help by sharing this information Reports News April 27, 2021 Find out more News RSF, IFEX-ALC and Media Defence, support FLIP and journalist Diana Díaz against state harassment in Colombia Receive email alertslast_img read more

PolarityTE Receives Allowance for Additional U.S. Patent

first_img Facebook SALT LAKE CITY–(BUSINESS WIRE)–Feb 3, 2021– PolarityTE, Inc. (Nasdaq: PTE) is pleased to report the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application No. 16/165,169 filed on October 19, 2018. This is the Company’s second patent allowance in the United States. The newly allowed claims provide additional protection for methods of making skin-regenerative compositions with the Company’s minimally polarized functional unit (MPFU) technology as well as methods of treatment utilizing the compositions. Additionally, a decision to grant Patent Application No. PI 2017701990 was recently issued in Malaysia. The allowed claims in Malaysia cover the same minimally polarized functional unit compositions as those patented in the United Kingdom. This news brings the Company’s total number of allowed patent applications and granted patents worldwide to nine. The Company continues to pursue additional patent applications in the United States and abroad related to its regenerative technologies, including SkinTE®. David Seaburg, Chief Executive Officer, commented, “The allowance of PolarityTE’s second U.S. patent is yet another step in protecting our valuable regenerative medicine assets, most notably SkinTE.” Mr. Seaburg continued, “This achievement further bolsters our patent portfolio and speaks to the steadfast efforts of the entire organization, including our intellectual property team.” Jennifer Burdman, Chief Intellectual Property Officer, commented, “As we’ve always said, the process of patent prosecution takes time and we are committed to the investment of our time and resources to protect PolarityTE’s patentable innovations through this process. We are now seeing our efforts pay off and are pleased that the USPTO has now twice recognized the patentability of our MPFU-related innovations.” About PolarityTE® PolarityTE is focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient’s own tissue and uses the patient’s own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic, and self-propagating product designed to regenerate the target tissues. PolarityTE’s innovative methods are intended to promote and accelerate growth of the patient’s tissues to undergo a form of effective regenerative healing. Learn more at www.PolarityTE.com – Welcome to the Shift®. About SkinTE® SkinTE is a human cellular and tissue-based product derived from a patient’s own skin (autologous) intended for the repair, reconstruction, replacement, or supplementation of skin tissue. Aseptic surgical procedures and handling during skin harvest, wound preparation, and SkinTE deployment are mandatory. SkinTE is currently marketed as a human cell, tissue, and cellular and tissue-based product regulated solely under Section 361 of the Public Health Service Act (PHS Act) and 21 CFR Part 1271 (i.e., as a 361 HCT/P). PolarityTE plans to file an investigational new drug application (IND) with FDA followed by a biologics license application (BLA) to have SkinTE regulated as a biologic under the federal Food Drug & Cosmetic Act and Section 351 of the PHS Act (i.e., as a 351 HCT/P), and will propose to FDA a plan for transitioning SkinTE from a 361 HCT/P to a 351 HCT/P. Forward Looking Statements Certain statements contained in this release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “intend,” “plan,” “will,” “would,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to the impact of the COVID-19 pandemic and FDA regulatory matters, which cannot be predicted, and the risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Report on Form 10-K and other filings with the SEC (copies of which may be obtained at www.sec.gov ). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law. POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are trademarks or registered trademarks of PolarityTE, Inc. View source version on businesswire.com:https://www.businesswire.com/news/home/20210203005922/en/ CONTACT: Investors: Rich Haerle VP, Investor Relations PolarityTE, Inc. [email protected] (385) 315-0697 KEYWORD: UTAH UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH OTHER HEALTH SOURCE: PolarityTE, Inc. Copyright Business Wire 2021. PUB: 02/03/2021 04:15 PM/DISC: 02/03/2021 04:16 PM http://www.businesswire.com/news/home/20210203005922/en By Digital AIM Web Support – February 3, 2021 Local NewsBusiness Pinterest Twitter Facebook TAGS  center_img Previous articleW. R. Berkley Corporation Announces Pricing of $300 Million of 4.125% Subordinated Debentures Due 2061Next articleOregon leads Pac-12 in recruiting for third straight year Digital AIM Web Support WhatsApp Pinterest Twitter WhatsApp PolarityTE Receives Allowance for Additional U.S. Patentlast_img read more